Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best NASDAQ stocks under $30 to buy. On March 16, Caris Life Sciences expanded its Caris AI Insights portfolio with a new AI signature designed to predict early platinum resistance in patients with high-grade serous ovarian cancer/HGSOC. This tool uses the company’s proprietary CodeAI platform to analyze Whole Exome Sequencing/WES, Whole Transcriptome Sequencing/WTS, and clinical data. The signature aims to provide clinicians with molecular foresight in ...